Earnings History Data for InMed Pharmaceuticals (INM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

InMed Pharmaceuticals

InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It engages in developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol in diseases with unmet medical need. InMed Pharmaceuticals Inc. is based in VANCOUVER, BC.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
10-11-2021 PM 7:30 AM ET
(Nov 10)
INM InMed Pharmaceuticals 13.00 -0.25 -0.35 0.00 InMed Pharmaceuticals reports FQ1 results
[11/10/2021 9:03 AM]
1.33 -0.07 
(-4.82%)
0.0 0.0 
(0.00%)
1.30 - 6.42 399,500 340,000 0
24-09-2021 PM 7:30 AM ET
(Sep 24)
INM InMed Pharmaceuticals Inc. 16.45 -0.41 -0.34 0.00 1.82 -0.01 
(-0.55%)
1.90 0.07 
(3.83%)
1.76 - 8.94 155,331 240,000 19,417
13-05-2021 PM
(May 13)
INM InMed Pharmaceuticals Inc. 28.34 -0.41 -0.24 0.00 InMed Pharmaceuticals reports FQ3 results
[5/13/2021 7:34 AM]
2.81 -0.57 
(-16.86%)
0.0 0.0 
(0.00%)
2.65 - 10.43 130,787 60,000 0
11-02-2021 PM INM InMed Pharmaceuticals Inc. 31.50 -0.37 -0.24 0.00 InMed Pharmaceuticals reports Q4 results
[2/11/2021 7:42 AM]
5.19 0.15 
(2.98%)
5.25 0.21 
(4.17%)
2.95 - 10.43 359,949 693,288 26,755